Agan, Bienvinido E.

HRN: 25-36-88  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/20/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/20/2026
02/26/2026
IV
500 Mg
Q8h
INTRAABDOMINAL INFECTION
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: